5,10-dihydro-5-methylphenazine has been researched along with Attention Deficit Disorder with Hyperactivity in 1 studies
*Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barry, RJ; Clarke, AR; Dupuy, FE; McCarthy, R; Selikowitz, M | 1 |
1 trial(s) available for 5,10-dihydro-5-methylphenazine and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
EEG coherence in girls with attention-deficit/hyperactivity disorder: stimulant effects in good responders.
Topics: Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Central Nervous System Stimulants; Child; Dose-Response Relationship, Drug; Electroencephalography; Female; Functional Laterality; Humans; Methylphenidate; Phenazines | 2008 |